生物活性 | |||
---|---|---|---|
描述 | Iruplinalkib (WX-0593) is a potent, selective, and orally bioavailable inhibitor of ALK and ROS1 tyrosine kinases, displaying favorable safety and promising antitumor efficacy in advanced NSCLC with ALK or ROS1 rearrangements[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.76mL 0.35mL 0.18mL |
8.79mL 1.76mL 0.88mL |
17.57mL 3.51mL 1.76mL |
参考文献 |
---|